SCHEMBL4209751

SCHEMBL4209751

CCc1nnnn1-c1ccc(OC)cc1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.62
LMNA P02545 7/20 0.51
NPSR1 Q6W5P4 2/20 0.51
TSHR P16473 2/20 0.51
RAB9A P51151 2/20 0.51
MAPT P10636 2/20 0.51
HTT P42858 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
PTGS2 P35354 1/20 0.48
PKM P14618 3/20 0.46
NLRP3 Q96P20 1/20 0.46
KDM4E B2RXH2 2/20 0.46
NPC1 O15118 1/20 0.46
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.45
TP53 P04637 1/20 0.45
HPGD P15428 1/20 0.45
GFER P55789 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4202133 0.87 ALDH1A1 (0.59) ALDH1A1LMNANPSR1TSHRRAB9A
SCHEMBL24240347 0.87 ALDH1A1 (0.49) ALDH1A1LMNANPSR1TSHRRAB9A
SCHEMBL8879926 0.85 ALDH1A1 (0.61) ALDH1A1LMNANPSR1TSHRRAB9A
SCHEMBL25217463 0.85 ALDH1A1 (0.61) ALDH1A1LMNANPSR1TSHRRAB9A
SCHEMBL8879929 0.85 ALDH1A1 (0.61) ALDH1A1LMNANPSR1TSHRRAB9A
SCHEMBL4211669 0.85 MAPT (0.56) ALDH1A1LMNANPSR1TSHRRAB9A
SCHEMBL4200649 0.83 PRMT1 (0.63) ALDH1A1LMNANPSR1MAPTHTT
SCHEMBL4212090 0.83 ALDH1A1 (0.60) ALDH1A1LMNANPSR1TSHRRAB9A
SCHEMBL4213822 0.83 PRMT1 (0.47) ALDH1A1LMNANPSR1MAPTHTT
SCHEMBL4204760 0.83 MAPT (0.53) ALDH1A1LMNANPSR1TSHRRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7579480-B2 Alkoxy-(tetrazol-1-yl)benzaldehyde compound and process for producing the same TOYO KASEI KOGYO COMPANY LIMITED (JP) 2009-08-25 US disclosed
CN-100402508-C Alkoxytetrazol-1-ylbenzaldehyde compound and process for producing the same TOYO KASEI KOGYO CO LTD (JP) 2008-07-16 CN disclosed
US-20070060630-A1 Alkoxy-(tetrazol-1-yl)benzaldehyde compound and process for producing the same TOYO KASEI KOGYO COMPANY LIMITED (JP) 2007-03-15 US disclosed
CN-1826329-A Alkoxy- (tetrazol-1-yl) benzaldehyde compound and process for producing the same TOYO KASEI KOGYO CO LTD (JP) 2006-08-30 CN disclosed
EP-1650198-A1 ALKOXYTETRAZOL-1-YLBENZALDEHYDE COMPOUND AND PROCESS FOR PRODUCING THE SAME Toyo Kasei Kogyo Company Limited (JP) 2006-04-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060630-A1 Alkoxy-(tetrazol-1-yl)benzaldehyde compound and process for producing the same ALDH7A1, NAT1, ARSA ALDH1A1 4/4885LMNA 2434/4885NPSR1 2735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.